Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis.

Elisa H IgnatiusKunbo Wang Andrew H KarabaMatthew RobinsonRobin K Avery Paul W BlairNatasha ChidaTania JainBrent G PettyZishan SiddiquiMichael T MeliaPaul G AuwaerterYanxun Xu Brian T Garibaldi

Published in: Open forum infectious diseases (2020)

Tocilizumab may provide benefit in a subgroup of patients hospitalized with COVID-19 who have elevated biomarkers of hyperinflammation, without increasing the risk of secondary infection.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
ejection fraction
newly diagnosed
juvenile idiopathic arthritis
rheumatoid arthritis patients
prognostic factors
clinical trial
cross sectional
patient reported outcomes
smoking cessation
combination therapy
study protocol
open label
replacement therapy